Solid cancers after allogeneic hematopoietic cell transplantation

Blood

Volumn 113, Issue 5, 2009, Pages 1175-1183

  Rizzo, J Douglas ^a   Curtis, Rochelle E ^b   Socié, Gérard ^c   Sobocinski, Kathleen A ^a   Gilbert, Ethel ^b   Landgren, Ola ^b   Travis, Lois B ^d   Travis, William D ^e   Flowers, Mary E D ^f   Friedman, Debra L ^f   Horowitz, Mary M ^a   Wingard, John R ^g   Deeg, H Joachim ^f  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Hô pital Saint Louis   (France)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD GROUP INCOMPATIBILITY; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER RISK; CARCINOMA; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HLA SYSTEM; HUMAN; INFANT; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CARCINOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SKIN CARCINOMA; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; T CELL DEPLETION; THYROID CANCER; ALLOTRANSPLANTATION; CHRONIC DISEASE; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; SECOND CANCER; SEX DIFFERENCE; TIME; WHOLE BODY RADIATION;

AGE FACTORS; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 60849115555     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-158782     Document Type: Article

References (43)

1. Curtis RE, Metayer C, Rizzo JD, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stemcell transplantation: an international case-control study. Blood. 2005;105:3802-3811.
2. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18:348-357.
3. Gallagher G, Forrest DL. Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer. 2007;109:84-92.
4. Shimada K, Yokozawa T, Atsuta Y, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant. 2005;36: 115-121.
5. Friedman DL, Leisenring W, Schwartz JL, Deeg HJ. Second malignant neoplasms following hematopoietic stem cell transplantation. Int J Hematol. 2004;79:229-234.
6. Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897-904.
7. Friedman DL, Rovo A, Leisenring W, et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood. 2008;111:939-944.
8. Kolb HJ, Socie G, Duell T, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation: Late EffectsWorking Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med. 1999;131:738-744.
9. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352-1358.
10. Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001;19:464-471.
11. Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24:1119-1126.
12. Cohen A, Rovelli A, Merlo DF, et al. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late EffectsWorking Party Study. J Clin Oncol. 2007;25:2449-2454.
13. Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103:2490-2497.
14. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
15. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. Vol VI. Lyon, France: International Agency for Research on Cancer (IARC scientific publications no. 120); 1992.
16. Muir CS,Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in Five Continents. Vol V. Lyon, France: International Agency for Research on Cancer (IARC scientific publilcations no. 88); 1987.
17. Breslow NE, Day NE. The design and analysis of cohort studies. In: Statistical Methods in Cancer Research. Vol II. Lyon, France: International Agency for Research on Cancer (IARC scientific publications no. 82); 1987.
18. Breslow NE. Elementary methods of cohort analysis. Int J Epidemiol. 1984;13:112-115.
19. Preston DL, Lubin JH, Pierce DA. Epicure user's guide. Seattle, WA: HiroSoft International; 1993.
20. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
21. Kaplan E. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.
22. National Research Council of the National Academies (Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation). Health risks from exposure to low levels of ionizing radiation: BEIR VII, Phase 2. Washington, D.C.: National Academies Press; 2006.
23. Curtis RE, Freedman DM, Ron E, et al. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Academy Press; 2006. NIH Publication no 05-5302:1-492.
24. van Leeuwen FE, Travis LB. Second cancers. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:2575-2602.
25. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465-475.
26. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004;141:590-597.
27. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer. 2007;121:2233-2240.
28. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484-3494.
29. Hodgson DC, Gilbert ES, Dores GM, et al. Longterm solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007;25: 1489-1497.
30. Ronckers CM, Sigurdson AJ, Stovall M, et al. Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat Res. 2006;166:618-628.
31. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005;365:2014-2023.
32. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528-1537.
33. Jenkinson HC, Winter DL, Marsden HB, et al. A study of soft tissue sarcomas after childhood cancer in Britain. Br J Cancer. 2007;97:695-699.
34. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007;99:300-308.
35. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-483.
36. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207-1215.
37. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349: 640-649.
38. Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood. 2002;99:4257-4264.
39. Boice JD Jr. Ionizing radiation. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:259-293.
40. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1-64.
41. Pasquini M. CIBMTR summary slides, 2005 Part 1. Center for International Blood and Marrow Transplant Research Newsletter 2006;12:5-8.
42. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol. 2005;23:5074-5087.
43. Cavalier M, Shmalo JA, Yu M, Billings SD, Abonour R, Nelson RP Jr. Skin cancer after nonmyeloablative hematopoietic cell transplantation. Bone Marrow Transplant. 2006;37:1103-1108.